Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories
L. I. Bader; S. M. Solberg; S. H. Kaada; N. Bolstad; D. J. Warren; S. Gavasso; C. G. Gjesdal; C. A. Vedeler
Author Information: The Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease (BEaBiRD)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.